News

The Phase II trial which is a randomized, double blind, placebo-controlled study, aims to evaluate the safety and efficacy of GLYX-13 in treatment-resistant depression. Naurex intends to recruit

Natco had earlier submitted an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) to market GSK’s generic version of Tykerb 250mg tablets. Tykerb

Levaquin is a synthetic broad spectrum antibacterial agent used to treat or prevent infections caused by susceptible bacteria. Lupin operates in Cardiovascular (prils and statins), Diabetology, Asthma, Pediatrics,

Xerclear, Medivir’s proprietary cream formulation, is a topical product indicated for the treatment of recurrent herpes labialis. As part of the distribution agreement, Daewoong will conduct clinical trials

The Toronto facility manufactures 5-component acellular pertussis combination vaccines, polio (IPV) vaccine, diphtheria and tetanus vaccines and has the ability to store paediatric vaccines to ensure secure supply

With this expansion, the company anticipates to add a 3,000 liter bioreactor train to increase commercial manufacturing in its PF2 site. The expansion, which is originally started in

Watson‘s Salt Lake City facility, which manufactures and packages branded and generic transdermal patch and topical gel pharmaceutical products, currently employs more than 200 people. As part of

Accenture has teamed up with Oracle, Hewlett-Packard and smaller companies like Orion Health and Initiate Systems in the Singapore health project. The system, developed with backup by the

The company expects to recruit around 200 patients in each of the trials. Earlier in July 2010, GSK has obtained license for this compound from Anacor Pharmaceuticals under